New Research: Novel miRNA-based drug CD5-2 reduces liver tumor growth in diethylnitrosamine-treated mice by normalizing tumor vasculature and altering immune infiltrate: Introduction

Liver cancers exhibit abnormal (leaky) vasculature,… #immunology frontiersin.org/articles/10.33…